Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?

Not available.

Saved in:

Bibliographic Details
Main Authors:	Francesca Negri (Author), Camillo Porta (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

Holdings details from 3rd Floor Main Library
Call Number:	A1234.567
Copy 1	Available